Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunnya is an Australian healthcare and nutrition company that specializes in the development, manufacturing, and export of premium health supplements and dairy products. The company operates several brands, most notably Slaite and NeuLait, which offer a range of products including infant formula, pregnancy supplements, and adult nutritional powders. Sunnya focuses on utilizing high-quality Australian ingredients to provide scientifically formulated health solutions for various life stages. Their business model is heavily oriented toward the international market, particularly the Asia-Pacific region, where they leverage Australia's reputation for food safety and quality. The company maintains a strong focus on research and development to ensure their formulations meet rigorous international standards. Sunnya is an active member of industry bodies such as the Infant Nutrition Council and Complementary Medicines Australia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunnya.